Research·October 23, 2026 at 7:30 AM EDT·1 source
Tango combo clears Rasonque bar, Takeda's Innovent bet gets early returns, plus more from #ESMO26
MRNA -1.2%MRK
MRNA · last 30 trading days-18.6% since the news
News
What happened
- Tango’s combination therapy cleared the Rasonque bar, according to Endpoints News.
- Takeda’s investment in Innovent is showing early returns at ESMO26.
- Anticipation for ESMO26 was reduced after data on Moderna and Merck’s cancer vaccine were leaked.
Why it matters
The update may inform healthcare investors and biopharma professionals assessing oncology data, partnerships and competitive positioning at ESMO26.
What to watch. Further ESMO26 data and conference presentations, including the Moderna-Merck cancer vaccine results.
Read more on YouBank
The Newsroom, ranked for your desk
About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.
Timeline
- EarlierOct 21Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data.
- First reported by Endpoints NewsOct 23Tango combo clears Rasonque bar, Takeda's Innovent bet gets early returns, plus more from #ESMO26
Who is involved
Tango combo clears Rasonque bar, Takeda's Innovent bet gets e…TangoRasonqueTakedaInnoventModernaMRNAMerckMRK
Company
Sources (1)
Related
- Yesterday · Wells Fargo, Cisco, Marvell among latest firms objecting to OKXICE's tokenized stock plan
- Oct 21 · Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data.
- Yesterday · STAT+: The ESMO presentation everyone’s been waiting for
- Yesterday · Cancer vaccine data from #ESMO26; Treasury proposal could curb China investment; and more
- Yesterday · Moderna Investors Should Brace for More Whiplash
- Oct 23 · The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.
Read more on YouBank
The Newsroom, ranked for your desk
About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.
- Why it matters to youEvery story matched to your watchlist, your contacts and your pipeline.
- Follow developing storiesAn alert, and a push, the moment a story you follow moves.
- Your briefing, read aloudA few minutes each morning with a chapter per story.
- Brief modeSwipe through the day, a 20-second card each.